This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Chongqing Zhien Pharmaceutical Co., Ltd., Sichuan University. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Xianglin Deng: Innovator in Pharmaceutical Chemistry
Introduction
Xianglin Deng is a notable inventor based in Chongqing, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative methods of synthesizing complex compounds. His work has implications for various applications in the pharmaceutical industry.
Latest Patents
Xianglin Deng holds a patent for the preparation method of (3S,4S)-3-hexyl-4-((R)-2-hydroxytridecyl)-oxetan-2-one. This invention relates to a method that includes several steps: reducing a specific substance to obtain another, oxidizing it, acylating n-octanoic acid to form n-octanoyl chloride, and then condensing it with 2-mercapto-pyridine. The final steps involve reacting the substances under catalytic conditions to generate the desired compound. This patent showcases his expertise in chemical synthesis and innovation.
Career Highlights
Throughout his career, Xianglin Deng has worked with prominent organizations such as Chongqing Zhien Pharmaceutical Co., Ltd. and Sichuan University. His experience in these institutions has allowed him to collaborate with other experts in the field and contribute to various research projects.
Collaborations
Xianglin Deng has collaborated with notable colleagues, including Yong Qin and Xuan Zhou. These partnerships have enhanced his research capabilities and fostered a collaborative environment for innovation.
Conclusion
Xianglin Deng is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable innovations. His patent for the preparation method of a complex compound exemplifies his contributions to the field. Through his career and collaborations, he continues to impact the pharmaceutical industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile